Search results for "Irritable bowel syndrome"


 
Results 1 - 10 of about 46 for "Irritable bowel syndrome".
Sort by: Relevance | Newest | Oldest

In primary care, second-line IBS therapy with amitriptyline vs. placebo reduced symptoms at 6 mo

An ACP Journal Club commentary said the high-quality randomized trial provides pragmatic guidance on amitriptyline dosing in patients with irritable bowel syndrome (IBS), as well as additional support for the drug as an option in primary care after first-line therapies fail.
https://gastroenterology.acponline.org/archives/2024/02/23/7.htm
23 Feb 2024

Spotlight on irritable bowel syndrome

Irritable bowel syndrome (IBS) was the focus of two recent studies this month, which analyzed patients with symptoms of diarrhea-predominant IBS and IBS after infectious enteritis.
https://gastroenterology.acponline.org/archives/2017/01/27/6.htm
27 Jan 2017

MKSAP Quiz: 3-month history of epigastric pain

A 40-year-old woman is evaluated for a 3-month history of epigastric pain, bloating, abdominal fullness, nausea, and diarrhea 30 to 60 minutes after meals that is worse with larger meals. Following a physical exam and other tests, what is the most appropriate treatment?
https://gastroenterology.acponline.org/archives/2024/01/26/4.htm
26 Jan 2024

Low-dose amitriptyline appears effective as second-line treatment for IBS

Patients with irritable bowel syndrome (IBS) who were randomized to titrated doses of a tricyclic antidepressant had significant improvements in their IBS symptom scores at six months compared to those receiving a placebo, a trial in primary care found.
https://gastroenterology.acponline.org/archives/2023/10/27/2.htm
27 Oct 2023

Spotlight on gluten avoidance

An industry-funded trial of patients with self-reported gluten sensitivity found that symptoms were tied to the expectation of gluten more than actual consumption, while a study of celiac disease patients found that their symptoms often persisted after elimination of gluten.
https://gastroenterology.acponline.org/archives/2023/12/22/5.htm
22 Dec 2023

Spotlight on irritable bowel syndrome

In the past month, researchers assessed potential treatments of irritable bowel syndrome (IBS), reviewed likely causes of the condition, and quantified the daily challenges facing patients with IBS.
https://gastroenterology.acponline.org/archives/2019/08/23/5.htm
23 Aug 2019

In irritable bowel syndrome, fecal microbiota transplantation improved symptoms at 3 months

While fecal microbiota transplantation was effective in patients with moderate to severe irritable bowel syndrome in a randomized trial, long-term risks of the therapy remain uncertain, an ACP Journal Club commentary noted.
https://gastroenterology.acponline.org/archives/2020/05/22/10.htm
22 May 2020

Treatments for irritable bowel syndrome examined

A network meta-analysis looked at trials comparing soluble fiber, antispasmodic drugs, peppermint oil, and gut-brain neuromodulators with each other or with placebo, while a randomized controlled trial tested fecal microbiota transplantation.
https://gastroenterology.acponline.org/archives/2019/12/27/1.htm
27 Dec 2019

New Annals Virtual Patients series features case on irritable bowel syndrome

Annals Virtual Patients is an interactive medical education program that uses virtual patient simulation to test physicians' decision-making skills.
https://gastroenterology.acponline.org/archives/2018/09/28/8.htm
28 Sep 2018

More tools available for treating IBS

Irritable bowel syndrome (IBS) is not a new disorder, but understanding of its pathophysiology and treatment has greatly progressed over the years.
https://gastroenterology.acponline.org/archives/2023/02/24/7.htm
24 Feb 2023

Result Page: Prev   1   2   3   4   5   Next